[Pain therapy with antipyretic analgesics].
Level 5 - mechanism / opinion, no new human data
Narrative review without systematic methodology or primary human trial data
PubMed 17171384 · doi:10.1007/s00132-006-1024-9
What was done
This narrative review examines the pharmacological management of musculoskeletal pain, focusing on acidic antipyretic analgesics (nonsteroidal anti-inflammatory drugs) and nonacidic agents (paracetamol, selective cyclooxygenase-2 inhibitors), specifically regarding their pharmacokinetic profiles and adverse effects.
What was found
The abstract provides no quantitative data, comparative statistics, or numerical outcomes.
Why it matters
It outlines pharmacokinetic differences and safety profiles across common analgesic classes used for musculoskeletal pain management.
Limits
The paper is an unstructured narrative review without systematic search methods, pooled analysis, or reported human sample sizes.
Cited by
- contradicts Acetaminophen belongs to the class of non-steroidal anti-inflammatory medications (NSAIDs).